StockData
TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

TANDEM DIABETES CARE INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$16.38+0.14 (+0.86%)

Close on Oct 19, 2026

Market cap
$1.13B
P/E (TTM)
–
Dividend yield
–

Tandem Diabetes Care statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison

Valuation

MeasureTandem Diabetes CareIndustry median
Market Cap$1.14B$230.55M
Enterprise Value$1.29B$202.97M
PS Ratio1.093.11
PB Ratio8.743.14
P/TBV Ratio8.744.57

Enterprise value

MeasureTandem Diabetes CareIndustry median
EV / Sales1.242.92

Income (trailing twelve months)

MeasureTandem Diabetes CareIndustry median
Revenue$1.04B$102.39M
Gross Profit$583.32M$60.36M
Operating Income-$45.80M-$4.31M
Pretax Income-$61.00M-$2.26M
Net Income-$63.32M-$6.57M
EBITDA-$27.83M-$1.98M
EPS (Diluted)-$0.93-$0.07

Margins

MeasureTandem Diabetes CareIndustry median
Gross Margin56.0%55.1%
Operating Margin-4.40%-6.04%
Pretax Margin-5.86%-4.11%
Profit Margin-6.08%-10.5%
EBITDA Margin-2.67%-2.67%
FCF Margin-2.56%-0.30%

Returns

MeasureTandem Diabetes CareIndustry median
Return on Equity (ROE)-48.0%-19.2%
Return on Assets (ROA)-6.24%-13.3%
Return on Invested Capital (ROIC)-17.9%-4.11%
Return on Capital Employed (ROCE)-5.08%-9.07%

Growth

MeasureTandem Diabetes CareIndustry median
Revenue Growth (YoY)3.96%8.85%
Revenue Growth (3Y CAGR)8.19%7.08%
Revenue Growth (5Y CAGR)15.3%11.8%

Balance sheet

MeasureTandem Diabetes CareIndustry median
Cash & Short-Term Investments$456.00M$37.33M
Total Debt$602.58M$72.66M
Net Cash (Debt)-$146.58M$3.92M
Net Cash Per Share-$2.11$0.28
Equity (Book Value)$130.39M$57.36M
Book Value Per Share$1.87$2.81
Tangible Book Value$130.39M$10.71M
Working Capital$551.63M$54.64M

Financial position

MeasureTandem Diabetes CareIndustry median
Current Ratio3.182.50
Quick Ratio2.441.54
Debt / Equity4.620.38
Interest Coverage-5.21-1.81

Cash flow (trailing twelve months)

MeasureTandem Diabetes CareIndustry median
Operating Cash Flow-$5.52M-$653.46K
Capital Expenditures-$21.10M-$3.69M
Free Cash Flow-$26.62M-$835.02K
FCF Per Share-$0.38-$0.02

Efficiency

MeasureTandem Diabetes CareIndustry median
Asset Turnover1.030.59
Inventory Turnover3.302.21
Revenue Per Employee$2.08K$322.57K
Profits Per Employee-$127-$51.88K
Employee Count500,000185

Dividends and yields

MeasureTandem Diabetes CareIndustry median
Earnings Yield-5.56%-6.91%
FCF Yield-2.34%-0.56%

Shares

MeasureTandem Diabetes CareIndustry median
Shares Outstanding69,578,70044,856,700
Shares Change (YoY)2.99%3.35%
Shares Change (QoQ)1.51%0.27%
Float68,753,00037,097,900
Shares Held by Insiders1.19%10.6%
Shares Held by Institutions113.3%63.5%

Taxes

MeasureTandem Diabetes CareIndustry median
Income Tax$2.32M$1.52M

Scores

MeasureTandem Diabetes CareIndustry median
Altman Z-Score0.441.95
Piotroski F-Score35
Beneish M-Score-3.11-2.64

Calculated by StockData from Tandem Diabetes Care's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.